Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The Diagnostic Imaging Devices market in South Africa has been experiencing steady growth in recent years, driven by customer preferences for advanced medical imaging technologies and the increasing demand for early and accurate diagnosis of medical conditions. Customer preferences in the Diagnostic Imaging Devices market in South Africa are largely influenced by global trends. Customers are increasingly seeking imaging devices that offer high image resolution, faster scanning times, and improved patient comfort. This is driving the demand for advanced technologies such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound devices. Additionally, there is a growing preference for portable and handheld imaging devices, particularly in rural areas where access to healthcare facilities is limited. The market is also witnessing a shift towards digital imaging technologies, as customers seek more efficient and cost-effective solutions. Digital imaging allows for easier storage, retrieval, and sharing of medical images, improving workflow efficiency and patient care. This trend is expected to continue driving the demand for digital radiography (DR) and picture archiving and communication systems (PACS). Local special circumstances in South Africa also play a role in the development of the Diagnostic Imaging Devices market. The country has a high burden of disease, with a significant prevalence of conditions such as HIV/AIDS, tuberculosis, and cardiovascular diseases. This has led to an increased need for diagnostic imaging devices for early detection and monitoring of these conditions. Additionally, the government has been investing in the development of healthcare infrastructure, including the establishment of new hospitals and clinics in underserved areas. This has created opportunities for the expansion of the Diagnostic Imaging Devices market in these regions. Underlying macroeconomic factors, such as population growth and increasing healthcare expenditure, are driving the growth of the Diagnostic Imaging Devices market in South Africa. The country has a growing population, which is contributing to the increasing demand for healthcare services. Furthermore, the government has been increasing its healthcare budget to improve access to quality healthcare services. This has resulted in increased investment in medical equipment, including diagnostic imaging devices. In conclusion, the Diagnostic Imaging Devices market in South Africa is developing in response to customer preferences for advanced imaging technologies, the shift towards digital imaging, local special circumstances such as a high burden of disease, and underlying macroeconomic factors such as population growth and increased healthcare expenditure. These factors are expected to continue driving the growth of the market in the coming years.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights